Who Paid My Doc
Accolade
Device Hips
PDI 04546540510525
General payments
$122,656,561
Research payments
$2,524,674
Through program year 2025, $122,656,561 in general payments and $2,524,674 in research payments were reported against Accolade (Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $23,909,373 | 864 |
| 2025 | Research | $366,906 | 6 |
| 2024 | General | $24,735,271 | 1,281 |
| 2024 | Research | $466,388 | 58 |
| 2023 | General | $25,825,674 | 2,192 |
| 2023 | Research | $511,888 | 55 |
| 2022 | General | $23,695,781 | 3,670 |
| 2022 | Research | $669,698 | 23 |
| 2021 | General | $24,490,462 | 2,599 |
| 2021 | Research | $509,795 | 17 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 22 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
10,606 general · 159 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.